Treatment of Psychosis in Parkinson’s DiseaseSafety Considerations

被引:0
|
作者
Hubert H. Fernandez
Martha E. Trieschmann
Joseph H. Friedman
机构
[1] Brown University School of Medicine,Department of Clinical Neurosciences
来源
Drug Safety | 2003年 / 26卷
关键词
Clozapine; Risperidone; Olanzapine; Quetiapine; Ziprasidone;
D O I
暂无
中图分类号
学科分类号
摘要
Psychosis only rarely occurs in patients with untreated Parkinson’s disease. Much more commonly, psychosis is induced by drug therapy for Parkinson’s disease and is the strongest known risk factor for nursing home placement. Delusions are less frequent than hallucinations, but are more concerning as they are often paranoid in nature. Treatment begins with a search for correctable infectious, toxic, and metabolic aetiologies. If symptoms persist, anti-Parkinson’s disease medications are slowly reduced. However, withdrawal of these drugs usually worsens parkinsonism and is often not tolerated. Certain atypical antipsychotics can be used to treat psychosis without compromising motor function.
引用
收藏
页码:643 / 659
页数:16
相关论文
共 50 条
  • [11] Ziprasidone in the treatment of Parkinson's disease psychosis
    Shiah, I-Shin
    Lin, Chun-Lung
    Mao, Wei-Chung
    Luu, Sy-Ueng
    EUROPEAN PSYCHIATRY, 2006, 21 (08) : 578 - 579
  • [12] Pimavanserin as treatment for Parkinson's disease psychosis
    Fox, Susan H.
    LANCET, 2014, 383 (9916): : 494 - 496
  • [13] Clozapine as a treatment of psychosis in Parkinson's disease
    Ozsancak, C
    Auzou, P
    Ronziere, T
    Hannequin, D
    Augustin, P
    PRESSE MEDICALE, 1997, 26 (33): : 1599 - 1602
  • [14] TREATMENT OF PSYCHOSIS IN PARKINSON
    Duran-Ferreras, E.
    Chacon, J. R.
    REVISTA DE NEUROLOGIA, 2009, 48 (12) : 645 - 653
  • [15] Pathophysiology and Treatment of Psychosis in Parkinson’s DiseaseA Review
    Laura B. Zahodne
    Hubert H. Fernandez
    Drugs & Aging, 2008, 25 : 665 - 682
  • [16] Pathophysiology and treatment of psychosis in Parkinson's disease - A review
    Zahodne, Laura B.
    Fernandez, Hubert H.
    DRUGS & AGING, 2008, 25 (08) : 665 - 682
  • [17] Treatment of memory and psychosis in patients with Parkinson's disease
    Isaacson, SH
    Kreitzman, DL
    MOVEMENT DISORDERS, 2005, 20 : S145 - S145
  • [18] Psychosis in Parkinson's disease: identification, prevention and treatment
    Levin, Johannes
    Hasan, Alkomiet
    Hoeglinger, Guenter U.
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (01) : 45 - 50
  • [19] Melperone in the treatment of iatrogenic psychosis in Parkinson's disease
    Barbato, L
    Monge, A
    Stocchi, F
    Nordera, G
    FUNCTIONAL NEUROLOGY, 1996, 11 (04) : 201 - 207
  • [20] Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease
    Broadstock, Martin
    Ballard, Clive
    Corbett, Anne
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 779 - 786